Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Apr 22 2026
Mar 25 2026
Aug 13 2025
Apr 21 2025
Feb 3 2026